Insight
Neeraj Agarwal Highlighted ASCO 2025 Presentation by Rana McKay on ETCTN Trial in mCRPC
Neeraj Agarwal and Rana McKay

Neeraj Agarwal Highlighted ASCO 2025 Presentation by Rana McKay on ETCTN Trial in mCRPC

Neeraj Agarwal, Postdoctoral fellow at City of Hope, shared a post on X:

“Stellar presentation at ASCO 2025 by trailblazer Rana McKay on ETCTN trial with radium +|- olaparib in mCRPC prostate cancer rPFS with the combo with/without HRRm.
Data continues to reinforce role of PARPi in rationale combinations,
Toni Choueiri – mentor.”

Rana McKay

Read OncoDaily’s Special Articles about ASCO 2025:

Highlights from ASCO 2025 Day 1

Highlights from ASCO 2025 Day 2

Highlights from ASCO 2025 Day 3

Highlights from ASCO 2025 Day 4

Rana McKay

 

ASCO ASCO 2025 ASCO25 cancer City of Hope ETCTN trial mCRPC Neeraj Agarwal olaparib OncoDaily Oncology PARP inhibitors prostate cancer radium Rana McKay Toni Choueiri